Milrinone-d3Milrinone-d3 - High-quality laboratory reagent available from Gentaur. Catalog: 804-HY-14252S.804-HY-14252S804-HY-14252SBusiness & Industrial > Science & LaboratoryMilrinone-d3
Gentaur
EUR12027-02-20

Milrinone-d3

CAT:
804-HY-14252S
Size:
500 μg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Milrinone-d3 - image 1

Milrinone-d3

  • Description:

    Milrinone-d3 is deuterium labeled Milrinone. Milrinone is a PDE3 inhibitor, and also an inotrope and vasodilator.
  • UNSPSC:

    12352005
  • Target:

    Isotope-Labeled Compounds; Phosphodiesterase (PDE)
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Metabolic Enzyme/Protease; Others
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Cardiovascular Disease
  • Solubility:

    10 mM in DMSO
  • Smiles:

    N#CC1=CC(C2=CC=NC=C2)=C(C([2H])([2H])[2H])NC1=O
  • Molecular Formula:

    C12H6D3N3O
  • Molecular Weight:

    214.24
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Hentschel T, et al. Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure. Anesthesiology. 2007 Jan;106 (1) :124-31.|[3]Kishi T, et al. Effects of milrinone on left ventricular end-systolic pressure-volume relationship of rat hearts in situ. Clin Exp Pharmacol Physiol. 2001 Sep;28 (9) :737-42.|[4]Santhosh KT, et al. Milrinone attenuates thromboxane receptor-mediated hyperresponsiveness in hypoxic pulmonary arterial myocytes. Br J Pharmacol. 2011 Jul;163 (6) :1223-36.|[5]Taylor MS, et al. Effect of milrinone on small mesenteric artery vasoconstriction: role of K (+) channels. Am J Physiol. 1999 Jul;277 (1 Pt 1) :G69-78.
  • Shipping Conditions:

    Room temperature
  • Scientific Category:

    Isotope-Labeled Compounds
  • Clinical Information:

    No Development Reported
  • CAS Number:

    [2749393-50-6]